\n<\/p>\n
Maximus\u00a0<\/strong>MMS<\/a> is benefiting from its reputation as a trusted partner to governments worldwide, delivering cost-effective, scalable solutions in health and human services. Strong shareholder-friendly policies and solid liquidity are added advantages.<\/p>\n<\/div>\n Meanwhile, regulatory risk and heavy reliance on contracts from federal and state governments pose significant concerns for the company. Heightened competition within the government services industry further puts pressure on profitability and scalability.<\/p>\n<\/div>\n Maximus gains from its business process management expertise and ability to deliver cost-effective, efficient and large-scale solutions, positioning it as a lucrative partner to governments. The company has grown to be a leading operator of government health and human services programs globally, enabling it to generate predictable recurring revenue streams. Improved quality of lifestyle and more complex health needs have increased the need for government social benefits and safety-net programs, consequently driving the company\u2019s top-line growth.<\/p>\n<\/div>\n Maximus, Inc. revenue-ttm<\/a> | Maximus, Inc. Quote<\/a><\/p>\n<\/div>\n MMS generates strong cash flow from operations, driven by its profitable operations and efficient receivables management. The subject-matter expertise of its workforce in the critical aspects of the design, implementation, and operation of government health and human services programs differentiates the company, giving it a competitive advantage over its peers.<\/p>\n<\/div>\n The company consistently rewards its shareholders through dividend payments. It paid dividends of $68.7 million, $72.9 million, $68.1 million and $68.7 million in fiscal 2025, 2024, 2023 and 2022, respectively. Such moves indicate the company\u2019s commitment to return value to shareholders and instill their confidence in the business.<\/p>\n<\/div>\n MMS\u2019s current ratio (a measure of liquidity) at the end of the first quarter of fiscal 2026 was 2.34, higher than the industry\u2019s 2.14.\u00a0A current ratio of more than 1 indicates that the company is well-positioned to pay off its short-term obligations.<\/p>\n<\/div>\n Meanwhile, Maximus continues to rely heavily on contracts from federal and state governments, particularly in programs like Medicaid and Medicare. The company is currently experiencing slowing growth in its core business segments due to this reliance. MMS\u2019s top line and contract volume can be directly impacted by changes in government funding priorities.<\/p>\n<\/div>\n The company operates in a highly regulated industry, which exposes it to significant regulatory risks. Policy shifts or changes to government healthcare programs under different political administrations could affect Maximus\u2019s ability to win contracts or sustain existing ones. Regulatory changes that tighten requirements for contractors could increase operational costs and reduce profits.<\/p>\n<\/div>\n Recently, MMS reported mixed first-quarter fiscal 2026 results. Earnings of $1.85 per share marginally beat the Zacks Consensus Estimate and increased 14.9% from the year-ago quarter. Total revenues of $1.4 billion missed the consensus estimate by 4.6% and dipped 4.1% year over year.<\/p>\n<\/div>\n Maximus currently carries a Zacks Rank #2 (Buy). You can see\u00a0the complete list of today\u2019s Zacks #1 Rank (Strong Buy) stocks here<\/strong><\/a>.<\/p>\n<\/div>\n FTI Consulting, Inc. <\/strong>FCN<\/a> reported impressive results for the fourth quarter of 2025.<\/p>\n<\/div>\n FCN\u2019s adjusted earnings per share of $1.78 beat the consensus mark by 39 cents and increased 14.1% from the year-ago quarter. FTI Consulting\u2019s revenues of $990.7 million beat the Zacks Consensus Estimate of $911.4 million and rose 10.7% from the year-ago quarter.<\/p>\n<\/div>\n Gartner, Inc. <\/strong>IT<\/a> posted impressive fourth-quarter 2025 results.<\/p>\n<\/div>\n IT\u2019s adjusted earnings were $3.94 per share, which beat the Zacks Consensus Estimate by 12.6%. The metric decreased 27.7% from the year-ago quarter. Gartner\u2019s total revenues of $1.8 billion beat the consensus estimate by a slight margin and improved 2.2% on a year-over-year basis.<\/p>\n<\/div>\n From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.<\/p>\n This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren\u2019t winners but this one could far surpass earlier Zacks\u2019 Stocks Set to Double like Nano-X $TWTR<\/a> Imaging which shot up +129.6% in little more than 9 months.<\/p>\nHow is MMS\u00a0Faring?<\/h2>\n
Maximus, Inc. Revenue (TTM)<\/h3>\n<\/div>\n
Earnings Snapshots of Some Other Service Providers<\/h2>\n
Research Chief Names “Single Best Pick to Double”<\/h2>\n